Durability of anti-vascular endothelial growth factor agents in neovascular age-related macular degeneration

被引：0
作者：
Sivaprasad, Sobha [1 ]
机构：
[1] Moorfields Eye Hosp, NIHR Moorfields Biomed Res Ctr, London, England
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2021年 / 49卷 / 06期
关键词：
THERAPY;
D O I：
10.1111/ceo.13973
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：540 / 541
页数：2
相关论文
共 50 条
  • [31] MACULAR ATROPHY INCIDENCE IN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR-TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Risk Factor Evaluation for Individualized Treatment Need of Ranibizumab or Aflibercept According to an Observe-and-Plan Regimen
    Mantel, Irmela
    Dirani, Ali
    Zola, Marta
    Parvin, Parmis
    De Massougnes, Sophie
    Bergin, Ciara
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (05): : 906 - 917
  • [32] Surgical choroidal neovascular membrane removal in the era of anti-vascular endothelial growth factor agents
    Nagpal, Manish
    Napal, Kamal
    Mehta, Vikram
    [J]. INDIAN JOURNAL OF OPHTHALMOLOGY, 2009, 57 (02) : 146 - 148
  • [33] Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration
    Krebs, Ilse
    Glittenberg, Carl
    Ansari-Shahrezaei, Siamak
    Hagen, Stefan
    Steiner, Irene
    Binder, Susanne
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (11) : 1443 - 1446
  • [34] Bioinformatics and Network Pharmacology Explore the Role of Immune Cells in the Occurrence of Anti-Vascular Endothelial Growth Factor (VEGF) Resistance in Patients with Neovascular Age-Related Macular Degeneration(nAMD) and the Application of Complementary Medicine Treatment
    Wang, Mingyan
    Li, Hongwei
    Wu, Yan
    Wang, Bingqi
    Xi, Ya
    Hu, Kaifeng
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2024, 32 (09) : 1945 - 1960
  • [35] Clinical Utilization of Anti-VEGF Agents and Disease Monitoring in Neovascular Age-Related Macular Degeneration
    Holekamp, Nancy M.
    Liu, Ying
    Yeh, Wei-Shi
    Chia, Yifeng
    Kiss, Szilard
    Almony, Arghavan
    Kowalski, Jonathan W.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2014, 157 (04) : 825 - 833
  • [36] Efficacy and Durability of Faricimab in Naïve Eyes with Neovascular Age-Related Macular Degeneration
    Toto, Lisa
    Formenti, Federico
    Ruggeri, Maria Ludovica
    Quarta, Alberto
    Romano, Anna
    De Nicola, Chiara
    Baroni, Luca Belloni
    Porreca, Annamaria
    Di Nicola, Marta
    Mastropasqua, Rodolfo
    [J]. OPHTHALMIC RESEARCH, 2024, 67 (01) : 528 - 536
  • [37] Anti-vascular endothelial growth factor agents for diabetic maculopathy
    Salam, A.
    DaCosta, J.
    Sivaprasad, S.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2010, 94 (07) : 821 - 826
  • [38] Different Clinical Courses on Long-Term Follow-Up of Age-Related Macular Degeneration Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections
    Sagiv, Oded
    Zloto, Ofira
    Moroz, Iris
    Moisseiev, Joseph
    [J]. OPHTHALMOLOGICA, 2017, 238 (04) : 217 - 225
  • [39] Surgical session: neovascular glaucoma and anti-vascular endothelial growth factor treatment
    Laplace, O.
    [J]. JOURNAL FRANCAIS D OPHTALMOLOGIE, 2009, 32 (03): : 230 - 235
  • [40] Bevacizumab for the Treatment of Neovascular Age-Related Macular Degeneration
    Pitlick, Jamie M.
    Vecera, Kayla F.
    Barnes, Kylie N.
    Reski, John W.
    Forinash, Alicia B.
    [J]. ANNALS OF PHARMACOTHERAPY, 2012, 46 (02) : 290 - 296
12345